Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06235216 | Sacituzumab govitEcan in THYroid Cancers | ||
| NCT04330846 | Prospective Multicenter Randomized Comparative Study of the Treatment of de Novo Stenosis in Chron's Disease. | ||
| NCT01684449 | Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma | ||
| NCT02806648 | A Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET) | ||
| NCT07248644 | Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission | ||
| NCT01564823 | Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease | ||
| NCT01956903 | Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell. | ||
| NCT01899079 | A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay | ||
| NCT03765333 | GETNE Registration of Thyroid Cancer | ||
| NCT03751176 | Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal | ||
| NCT01288339 | Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer | ||
| NCT05201612 | Pembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC). | ||
| NCT02340949 | Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer | ||
| NCT02678780 | Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors | ||
| NCT01262482 | Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based Treatment | ||
| NCT00909987 | Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum | ||
| NCT06844318 | Impact of IBD Activity on Frailty in Patients Over 60 Years | ||
| NCT01493713 | Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer | ||
| NCT03242382 | Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. | ||
| NCT06031038 | Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU | ||
| NCT04595994 | Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma | ||
| NCT04383288 | ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities | ||
| NCT01683123 | Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT | ||
| NCT02066285 | Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma | ||
| NCT05146440 | Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor | ||
| NCT00541840 | Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma | ||
| NCT02904590 | A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease | ||
| NCT01389440 | Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic Cancer | ||
| NCT01104298 | Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS | ||
| NCT04138381 | Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST) | ||
| NCT03727113 | Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors | ||
| NCT02254941 | Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer | ||
| NCT06211543 | Letermovir (LMV) Prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients With CMV Seropositive Donors: an Exploratory Study From Spanish GETH/TC Centers | ||
| NCT03980925 | Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin. | ||
| NCT04986085 | Nutrition in Gastroenteropancreatic Neuroendocrine Tumor | ||
| NCT01567488 | Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET | ||
| NCT05390671 | CAR-T Cell Therapy in Patients With Hematological Malignancies | ||
| NCT06837090 | Retrospective Analysis of the Experience With Larotrectinib in Patients With Solid Neoplasms With NTRK Fusion in Spain (SPAINTRK) | ||
| NCT03000374 | Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery | ||
| NCT05698745 | Immunological Characteristics of Preclinical IBD | ||
| NCT03277924 | Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas | ||
| NCT01710176 | Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy | ||
| NCT03142516 | FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status | ||
| NCT00083174 | Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer | ||
| NCT03753919 | Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial | ||
| NCT01280201 | Pazopanib as Single Agent in Advanced NETs | ||
| NCT04400474 | Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study | ||
| NCT01067053 | Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients. | ||
| NCT02638766 | Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST | ||
| NCT01455051 | Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation |
